First Episealer® Talus surgery performed in Portugal
Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery in Portugal with the ankle implant Episealer® Talus has been performed this week. Prof. Bruno Pereira performed the surgery at Hospital de Santa Maria – Porto, assisted by Prof. Niek van Dijk with support from Episurf and Medcomtech. Since previously, the Episealer® Knee technology is available in Portugal.
“We are now offering the Episealer® Talus technology to our Portuguese customers, and we are pleased with having the first surgery in Portugal performed. We would also like to thank Medcomtech for a successful collaboration during this operation. Episurf’s Episealer® implants for the knee joint have been used in Portugal for some time”, says Pål Ryfors, CEO Episurf Medical.
For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.
Tags: